实用医学杂志 ›› 2021, Vol. 37 ›› Issue (23): 2993-2997.doi: 10.3969/j.issn.1006⁃5725.2021.23.007

• 基础研究 • 上一篇    下一篇

青蒿素对大鼠自体移植静脉桥内膜增生的影响

黄强信 周念 冯志强 韦懿桐   

  1. 广西中医药大学第一附属医院胸心血管外科(南宁 530023)

  • 出版日期:2021-12-10 发布日期:2021-12-10
  • 基金资助:
    广西医疗卫生适宜技术开发与推广应用项目(编号:S201679)

Effects of artemisininon intimal hyperplasia in autogenous vein grafts in rats

HUANG Qiangxin,ZHOU Nian,FENG Zhiqiang,WEI Yitong.   

  1. Department of Cardiothoracic Surgery,the First Affiliated Hospital of Guangxi University of Chinese Medicine,Nanning 530023,China

  • Online:2021-12-10 Published:2021-12-10
  • Supported by:


摘要:

目的 探讨青蒿素对大鼠自体移植静脉桥内膜增生的影响。方法 将雄性 Sprague⁃Dawley (SD)大鼠32只建立自体静脉移植模型,随机分为两组:实验组(16只)和对照组(16只)。实验组于造模前 1 d 给予青蒿素 100 mg/(kg·d)灌胃直至取材,对照组相同时间给予等体积生理盐水灌胃。两组动物分别 于造模后 2 周和 4 周取材备检,每个时间点 8 只。应用图像分析仪计算新生内膜厚度,免疫组织化学方法 检测平滑肌 22α(SM22α)的表达变化及 Western bolt 检测 SM22α 蛋白表达变化情况。结果 实验组术后 2 周、4 周静脉桥新生内膜厚度与同期对照组比较明显减少[(20.79 ± 1.88)μm vs.(35.23 ± 2.66)μm,P< 0.01;(37.06 ± 2.22)μm vs.(46.23 ± 2.54)μm,P<0.01]。SM22α在静脉桥平滑肌细胞有表达,实验组SM22α 蛋白表达阳性率在术后 2、4 周较同期明显抑制下降[(59.20 ± 5.76)vs.(26.12 ± 3.72),P<0.01;(35.63 ± 4.36)vs.(10.38 ± 2.98),P<0.01]。实验组 SM22α 蛋白含量(SM22α/β⁃Actin)在术后 2、4 周较同期明显抑 制下调[(0.58 ± 0.1)vs.(0.39 ± 0.06),P<0.01;(0.42 ± 0.06)vs.(0.21 ± 0.05),P<0.01]。结论 青蒿素可 明显抑制静脉桥内膜增生,原因可能与其抑制血管SM22α 的表达下调,从而抑制平滑肌细胞增殖有关。

关键词: 青蒿素,  , 平滑肌22α,  , 内膜增生,  , 再狭窄

Abstract:

Objective To study the effects of artemisinin on intimal hyperplasia in autogenous vein grafts in rats. Methods Jugular vein⁃to⁃artery bypass grafting was performed on 32 male Sprague⁃Dawley rats.The rats were randomly divided into two groups:the treatment group(n = 16)and the control group(n = 16). The treatment group was given gastric perfusion artemisinin 100 mg/(kg · d)which began 1 day before operation and continued until harvesting,and the control group was given to the same volume with normal saline by the same way. At 2 or 4 weeks after surgery,vein grafts were harvested,with 8 rats for each time point. Computer image analysis system was applied tocalculate the thickness of neointima in the vein grafts,expression area of smooth muscle 22α(SM22α)was identi⁃ fied by immunohistochemical observationand the protein level of SM22α was detected by Western bolt. Results After 2 or 4 weeks,neointima thickness of the vein graft in the treatment group was significantly reduced compared with that of the control group[(20.79 ± 1.88)μm vs.(35.23 ± 2.66)μm,P<0.01;(37.06 ± 2.22)μm vs.(46.23 ± 2.54)μm,P<0.01]. The expression of SM22α protein was detected in smooth muscle cells of vein graft after surgery. The positive rate of SM22α protein expression were significantly inhibited in the treatment group than that of the control group[(59.20 ± 5.76)vs.(26.12 ± 3.72),P<0.01;(35.63 ± 4.36)vs.(10.38 ± 2.98),P<0.01]. The protein expression levels of SM22α(SM22α/β ⁃Actin)were significantly inhibitedin the treatment group than that of the control group[(0.58 ± 0.1)vs.(0.39 ± 0.06),P<0.01;(0.42 ± 0.06)vs.(0.21 ±0.05),P<0.01]. Conclusion Artemisinin could obviously inhibit hyperplasia of intimal thickness after venous transplantation,which may be relat⁃ ed to inhibit the lower the expression of SM22α and inhibition of smooth muscle cell proliferation.

Key words: artemisininsmooth,  , muscle 22α,  , intimal hyperplasia,  , restenosis